Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic study of dermal small-particle cross-linked hyaluronic acid for skin rejuvenation
ChiCTR2100050268Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of hyaluronic acid in cutaneous aging and photoaging (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Differences in collagen expression at week 24 and Differences in expression of elastin-related proteins at week 24. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
hyaluronic acid
03
Conditions
cutaneous agingphotoaging
Beyond the preview
Go deeper on ChiCTR2100050268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050268.